Showing results (101-110 of 45,933) with videos related to
Sort By:
Pageof 4,594
The Journal of Pharmacy and Pharmacology|March 1, 1996
Glibenclamide antagonizes the inhibitory effect of morphine on gall bladder emptyingB M Patil, P R ThakkerUrology Case Reports|June 2, 2017
Renal Myxoma, an Incidental FindingParth Thakker, Tam Ramsey, Fernando NavarroJournal of Pharmaceutical Sciences|January 6, 2004
High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolismJohn H Ansede, Dhiren R ThakkerHuman Mutation|September 20, 2007
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the geneManuel C Lemos, Rajesh V ThakkerAnnals of the New York Academy of Sciences|November 16, 2011
Transcription factors in parathyroid development: lessons from hypoparathyroid disordersIrina V Grigorieva, Rajesh V ThakkerJournal of Pharmaceutical Sciences|September 1, 1980
Stability of solid drugs: degradation of ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) at high humidities and elevated temperaturesL T Grady, K D ThakkerBiochemistry|October 7, 1975
Affinity labeling of catechol O-methyltransferase by N-haloacetyl derivatives of 3,5-dimethoxy-4-hydroxyphenylethylamine and 3,4-dimethoxy-5-hydroxyphenylethylamine. Kinetics of inactivationR T Borchardt, D R ThakkerClinical Pharmacokinetics|September 24, 2014
A physiologically based pharmacokinetic model for voriconazole disposition predicts intestinal first-pass metabolism in childrenNicole R Zane, Dhiren R ThakkerBiochimica Et Biophysica Acta|October 11, 1976
Evidence for sulfhydryl groups at the active site of catechol-O-methyltransferaseR T Borchardt, D R ThakkerEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 2, 2011
Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practicePaul J Newey, Rajesh V ThakkerPageof 4,594